Mustang Bio
MBIO
27 hedge funds and large institutions have $3.94M invested in Mustang Bio in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 28 closing their positions.
9% more capital invested
Capital invested by funds: $3.6M → $3.94M (+$339K)
0.16% more ownership
Funds ownership: 0.01% → 0.17% (+0.16%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
44% less funds holding
Funds holding: 48 → 27 (-21)
75% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KOC
Koss-Olinger Consulting
Gainesville,
Florida
|
+$502K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$135K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$98.2K |
| 4 |
BlackRock
New York
|
+$69.8K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$51.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
-$228K |
| 2 |
Renaissance Technologies
New York
|
-$170K |
| 3 |
SAG
Spotlight Asset Group
Oakbrook Terrace,
Illinois
|
-$138K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$114K |
| 5 |
Millennium Management
New York
|
-$102K |
MBIO Hedge Fund Activity: Q2 2023 in Review
27 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2023, worth a combined $3.94M — up 9.4% from $3.6M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of MBIO and 7 opened new positions — a net loss of 21 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Koss-Olinger Consulting, opening a new position worth an estimated $502K. The largest seller was Laurion Capital Management, cutting an estimated $228K.
- 27 institutional investors held Mustang Bio (MBIO) as of Q2 2023, down from 48 in Q1 2023.
- Funds reported $3.94M of Mustang Bio stock for Q2 2023, up 9.4% quarter-over-quarter.
- 7 funds opened new Mustang Bio positions in Q2 2023 and 28 closed out, a net change of -21 holders.
- The largest Mustang Bio buyer in Q2 2023 was Koss-Olinger Consulting, an estimated $502K added.
- The largest Mustang Bio seller in Q2 2023 was Laurion Capital Management, an estimated $228K sold.
Based on aggregated 13F filings for Q2 2023.